Professional Summary
Professional Overview
Brian Johnstone is a seasoned research executive with over 20 years of experience in the biotechnology and pharmaceutical industries. As the Vice President of Research at Ossium Health, he leads a team of scientists focused on developing innovative regenerative medicine solutions. With a strong background in cardiovascular research and preclinical development, Johnstone has made significant contributions to advancing novel therapeutic approaches.
Experience Summary
Current Role
As the Vice President of Research at Ossium Health, Johnstone is responsible for overseeing all research and development activities. He manages a cross-functional team of researchers, scientists, and technicians, ensuring the successful execution of key projects and the alignment of research initiatives with the company's strategic objectives. Under his leadership, Ossium Health has made significant advancements in its pipeline of regenerative medicine products, with several candidates progressing through preclinical development.
Career Progression
Prior to his current role, Johnstone served as the Senior Director of Research & Development at Ossium Health, where he played a pivotal role in the company's growth and the expansion of its research capabilities. He has also co-founded Chemigen, LLC, a biotechnology company focused on developing novel chemical compounds for various applications.
Earlier in his career, Johnstone held roles as the Co-Founder and Director of R&D at NeuroFx (now Theratome Bio), as well as a Research Scientist at Sangamo BioSciences. Throughout his career, he has demonstrated a strong track record of successful project management, strategic planning, and innovative research that has contributed to advancements in the field of regenerative medicine.
Academic Background
Johnstone holds a Ph.D. in Biomedical Engineering from Indiana University School of Medicine, where he also served as an Adjunct Research Professor and an Associate Research Professor. His doctoral research focused on the development of innovative cell-based therapies for cardiovascular diseases.
Areas of Expertise
- Regenerative medicine and tissue engineering
- Cardiovascular research and preclinical development
- Cell and gene therapy
- Translational research and clinical trial design
- Cross-functional team management and leadership
- Collaborative research and development partnerships
Professional Impact
Johnstone's research has been widely published in peer-reviewed journals, and he has been an active contributor to various industry conferences and symposia. He has also served on the editorial board of several scientific journals and has been involved in the review of grant proposals for funding agencies. Through his work, Johnstone has made significant contributions to advancing the field of regenerative medicine and improving patient outcomes.
Conclusion
With his extensive experience, strong research capabilities, and proven track record of success, Brian Johnstone is a valuable asset to Ossium Health and the broader biotechnology industry. As the Vice President of Research, he continues to drive innovation, foster collaborative partnerships, and lead a talented team of researchers in the pursuit of groundbreaking regenerative medicine solutions.
